CSS
PRAH

Cubist Systematic Strategies’s PRA Health Sciences, Inc. PRAH Stock Holding History

Cubist Systematic Strategies’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,107
Closed -$844K – 3330
2021
Q2 		$844K Buy
5,107
+3,720
+268% +$621K 0.01% 1697
2021
Q1 		$213K Sell
1,387
-13,326
-91% -$1.81M ﹤0.01% 2431
2020
Q4 		$1.85M Buy
14,713
+7,534
+105% +$843K 0.03% 994
2020
Q3 		$728K Buy
7,179
+423
+6% +$43.1K 0.01% 1514
2020
Q2 		$657K Buy
6,756
+71
+1% +$6.61K 0.01% 1438
2020
Q1 		$555K Sell
6,685
-41,771
-86% -$4.07M 0.02% 1188
2019
Q4 		$5.39M Buy
48,456
+31,480
+185% +$3.24M 0.1% 272
2019
Q3 		$1.69M Sell
16,976
-33,465
-66% -$3.32M 0.03% 703
2019
Q2 		$5M Buy
50,441
+44,323
+724% +$4.23M 0.09% 303
2019
Q1 		$675K Buy
6,118
+887
+17% +$92.7K 0.02% 993
2018
Q4 		$481K Sell
5,231
-4,822
-48% -$488K 0.02% 997
2018
Q3 		$1.11M Sell
10,053
-4,054
-29% -$422K 0.06% 429
2018
Q2 		$1.32M Buy
14,107
+4,687
+50% +$404K 0.07% 368
2018
Q1 		$781K Buy
9,420
+1,333
+16% +$118K 0.05% 554
2017
Q4 		$736K Buy
8,087
+604
+8% +$50.2K 0.04% 659
2017
Q3 		$570K Sell
7,483
-824
-10% -$62.3K 0.03% 744
2017
Q2 		$623K Buy
8,307
+814
+11% +$56.4K 0.04% 641
2017
Q1 		$489K Sell
7,493
-7,390
-50% -$435K 0.03% 649
2016
Q4 		$820K Buy
14,883
+7,004
+89% +$384K 0.07% 443
2016
Q3 		$445K Sell
7,879
-2,973
-27% -$146K 0.03% 764
2016
Q2 		$453K Buy
+10,852
New +$500K 0.03% 835
2016
Q1 		– Sell
-4,593
Closed -$208K – 1922
2015
Q4 		$208K Buy
+4,593
New +$193K 0.01% 1333
2015
Q3 		– Sell
-13,578
Closed -$493K – 2080
2015
Q2 		$493K Sell
13,578
-7,648
-36% -$242K 0.02% 973
2015
Q1 		$612K Buy
21,226
+6,686
+46% +$186K 0.03% 810
2014
Q4 		$352K Buy
+14,540
New +$328K 0.02% 1102

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Cubist Systematic Strategies's PRAH Position: Q3 2021 in Review

Cubist Systematic Strategies sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 5,107 shares — an estimated $844K sold.

Cubist Systematic Strategies first reported a position in PRAH in Q4 2014 and held it in 25 quarters. The position peaked at $5.39M in Q4 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Cubist Systematic Strategies reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 5,107 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $844K.
  • Cubist Systematic Strategies first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 25 quarters.
  • Cubist Systematic Strategies's PRA Health Sciences, Inc. position peaked at $5.39M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Cubist Systematic Strategies's 13F filing for Q3 2021, filed 15 Nov 2021.